Alibaba Health Info Tech Stock (OTC: ALBBY)

Latest news for Alibaba Health Info Tech (OTC:ALBBY) Stock

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Asia

Markets

General

ALBBY

JDHIF

Key Takeaways:


	The gross margin on the company’s proprietary drug distribution business, its main revenue source, edged down to 6.1% last year
	With the pharma market already well developed, several distribution giants have muscled onto YSB’s turf as suppliers to pharmacies and smaller clinics


By Molly Wen

Slowing Revenue Growth Hurts Online Drug Platform YSB

ALIBABA HEALTH UNSP/ADR by Alibaba Health Information Technology Ltd

Alibaba Health Information Technology Ltd

With U.S. markets closed for Independence Day, European stocks and currencies rose on Thursday, showing no signs of risk aversion despite the ongoing <a href="https://www.benzinga.com/markets/eurozone/24/05/39048040/uk-election-how-it-works-and-which-markets-could-be-affected">UK legislative elections</a>.
The Labour Party is expected to achieve a landslide victory, ending 14 consecutive years of Conservative (or Tories) leadership. Heading to the elections, the Labour Party led by about 20 percentage points against Tories.
Polls will close at 5:00 p.m. ET on Thursday, with results expected later tonight.
<h3 class="wp-block-heading">UK Stocks And Sterling</h3>
Ipek Ozkardeskaya, an analyst at Swissquote Bank Ltd, outlined two likely scenarios: a strong Labour majority with 150 seats — nearly double Boris Johnson&#8216;s 80-seat majority in 2019 — or a super majority with 250 seats. 
Both outcomes would enable Labour to enact significant reforms in the UK.
&#8220;Even investors want to see Labour take over the reins this time,&#8221; she remarked.
Analysts perceive a Labour victory as positive for UK stocks and sterling. Ozkardeskaya highlighted that small and medium-sized British stocks will benefit more than the FTSE 100, which is heavily influenced by global market dynamics.
On Thursday, the FTSE 100 Index rose over 1%, marking its second consecutive day in the green. Smith &amp; Nephew led gains, up 7.6% following Cevian Capital&#8216;s acquisition of a 5% stake. Bunzl and Melrose each rose by 2.9%, while Barclays plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCS#NYSE">BCS</a>) led the banking sector with a 2.1% increase.
The British pound, tracked by the Invesco CurrencyShares British Pound Sterling ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXB#NYSE">FXB</a>), edged 0.2% higher, marking its sixth consecutive session of gains. The euro saw similar performance.
<h3 class="wp-block-heading">Other Movers On Thursday</h3>
The dollar weakened against all major currencies, with the Japanese yen gaining 0.3% against the greenback.
Confidence that Marine Le Pen&#8216;s far-right National Rally will not obtain an absolute majority at the second round of French elections this Sunday buoyed other European markets.
The French CAC 40 index rose 0.8%, as did the Italian FTSE Mib, while the German DAX inched 0.4% higher.
The broader Euro STOXX 50 Index, tracked by the SPDR DJ Euro STOXX 50 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FEZ#NYSE">FEZ</a>), closed 0.4% higher, notably surging above the key 50-day moving average for the first time since June 13.
Chart: Euro STOXX 50 Index Closes Above 50-Day Average
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7-1024x500.png" alt="" class="wp-image-420262" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7-1536x750.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/04121958/image-7.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In commodities markets, copper rallied 0.9%, marking its fifth straight positive session. Gold rose 0.2%, while silver fell 0.2%.
Oil prices showed robust gains, with West Texas Intermediate (WTI) light crude futures climbing to $84, up 0.8%.
Cryptocurrencies were the weakest market segment:
<ul>
<li>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) down 3.8%</li>
<li>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) down 4.1%</li>
<li>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) down 5%</li>
<li>Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) down 5.1%</li>
<li>Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) down 5.4%.</li>
</ul>
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/07/39634920/july-fourth-cookout-inflation-hits-record-highs-your-grocery-bill-may-be-a-shock-but-this-side-dish">July Fourth Cookout Inflation Hits Record Highs &#8211; &#8216;Your Grocery Bill May Be A Shock&#8217; But This Side Dish Costs Less, Expert Says</a></li>
</ul>
Image: Pixabay

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Large Cap

Specialty ETFs

Eurozone

Commodities

Econ #s

ETFs

$ADA

$BTC

$ETH

$SOL

$XRP

CurrencyShares British Pound Sterling Trust

British Pound, European Stocks Surge Ahead Of UK Election Results; Bitcoin Plummets: What's Driving Markets Thursday?

Zoetis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) has outperformed the market over the past 10 years by 7.56% on an annualized basis producing an average annual return of 18.39%. Currently, Zoetis has a market capitalization of $80.07 billion. 
Buying $100 In ZTS: If an investor had bought $100 of ZTS stock 10 years ago, it would be worth $540.64 today based on a price of $175.48 for ZTS at the time of writing.
<h3>Zoetis's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720112424_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today

Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) has outperformed the market over the past 10 years by 3.31% on an annualized basis producing an average annual return of 14.14%. Currently, Applied Industrial Techs has a market capitalization of $7.39 billion. 
Buying $1000 In AIT: If an investor had bought $1000 of AIT stock 10 years ago, it would be worth $3,747.55 today based on a price of $191.35 for AIT at the time of writing.
<h3>Applied Industrial Techs's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720112419_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Applied Industrial Techs Stock In The Last 10 Years

<h3>Gainers</h3>
<ul>
<li>JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXJT#NASDAQ">JXJT</a>) shares increased by 13.3% to $1.7 during Thursday's regular session. The market value of their outstanding shares is at $10.3 million. </li>
<li>Koss (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) shares increased by 9.59% to $11.65. The company's market cap stands at $107.8 million. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock rose 7.27% to $0.29. The company's market cap stands at $1.1 million. </li>
<li>Kirkland's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIRK#NASDAQ">KIRK</a>) shares rose 4.99% to $1.68. The market value of their outstanding shares is at $21.9 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 4.95% to $15.46. The company's market cap stands at $57.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ToughBuilt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLT#NASDAQ">TBLT</a>) stock fell 10.8% to $4.47 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. </li>
<li>BurgerFi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) shares declined by 9.16% to $0.17. The company's market cap stands at $4.7 million. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock fell 4.85% to $0.18. The company's market cap stands at $9.4 million. </li>
<li>ContextLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) shares decreased by 4.6% to $5.49. The company's market cap stands at $134.3 million. </li>
<li>Lead Real Estate Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRE#NASDAQ">LRE</a>) shares decreased by 3.72% to $1.81. The company's market cap stands at $24.6 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) stock declined by 3.51% to $1.1. The company's market cap stands at $11.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

GNLN

JXJT

KIRK

KOSS

LOGC

RENT

TBLT

11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Qualigen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) shares moved upwards by 42.5% to $0.25 during Thursday's regular session. The company's market cap stands at $1.5 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) stock rose 33.56% to $0.31. The market value of their outstanding shares is at $6.1 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares increased by 21.43% to $0.78. The market value of their outstanding shares is at $14.6 million. </li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) stock rose 11.68% to $1.29. The company's market cap stands at $189.2 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) stock rose 10.74% to $0.71. The company's market cap stands at $52.3 million. </li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares rose 10.54% to $0.76. The market value of their outstanding shares is at $75.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock declined by 7.0% to $0.21 during Thursday's regular session. The company's market cap stands at $4.9 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) stock declined by 6.17% to $1.37. The company's market cap stands at $1.1 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares decreased by 5.78% to $0.72. The market value of their outstanding shares is at $2.7 million. </li>
<li>Ainos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>) stock fell 5.33% to $0.89. The market value of their outstanding shares is at $5.7 million. </li>
<li>Tenax Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENX#NASDAQ">TENX</a>) shares fell 5.2% to $3.02. The company's market cap stands at $5.9 million. </li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) stock decreased by 5.11% to $2.23. The market value of their outstanding shares is at $8.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIMD

AMIX

CMAX

CNSP

FGEN

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RSLS

STSS

TENX

TNON

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Multi Ways Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MWG#AMEX">MWG</a>) shares rose 11.1% to $0.43 during Thursday's regular session. The market value of their outstanding shares is at $13.2 million. </li>
<li>LiqTech Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>) shares moved upwards by 10.04% to $2.41. The company's market cap stands at $13.9 million. </li>
<li>FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) stock moved upwards by 8.5% to $0.33. The market value of their outstanding shares is at $41.4 million. </li>
<li>Shapeways Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPW#NASDAQ">SHPW</a>) stock moved upwards by 5.31% to $0.28. The company's market cap stands at $1.8 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) shares increased by 5.25% to $2.4. The market value of their outstanding shares is at $79.7 million. </li>
<li>Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) shares moved upwards by 4.96% to $10.35. The company's market cap stands at $235.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares decreased by 12.2% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $10.4 million. </li>
<li>Sunrise New Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) shares decreased by 5.24% to $0.83. The company's market cap stands at $21.7 million. </li>
<li>noco-noco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNC#NASDAQ">NCNC</a>) shares fell 3.73% to $0.17. The market value of their outstanding shares is at $23.0 million. </li>
<li>Matrix Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) stock fell 3.7% to $8.86. The market value of their outstanding shares is at $241.9 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) stock declined by 3.46% to $1.66. The market value of their outstanding shares is at $44.0 million. </li>
<li>FTAI Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) stock fell 3.2% to $9.1. The company's market cap stands at $925.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BYRN

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

FTCI

LIQT

MTRX

NCNC

NEOV

PDYN

SHPW

ZCAR

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) shares increased by 5.4% to $0.97 during Thursday's regular session. The company's market cap stands at $111.7 million. </li>
<li>Minim (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) stock moved upwards by 4.93% to $3.4. The market value of their outstanding shares is at $9.5 million. </li>
<li>Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) stock increased by 4.88% to $2.79. The company's market cap stands at $76.9 million. </li>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) shares increased by 4.79% to $12.25. The company's market cap stands at $145.5 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares moved upwards by 4.64% to $0.15. The market value of their outstanding shares is at $4.4 million. </li>
<li>American Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) shares rose 4.4% to $9.48. The company's market cap stands at $315.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) stock declined by 13.1% to $2.78 during Thursday's regular session. The market value of their outstanding shares is at $33.1 million. </li>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares decreased by 8.3% to $2.71. The market value of their outstanding shares is at $275.3 million. </li>
<li>Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) stock fell 5.83% to $0.15. The market value of their outstanding shares is at $4.1 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock decreased by 5.55% to $0.37. The company's market cap stands at $5.4 million. </li>
<li>CLPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPS#NASDAQ">CLPS</a>) stock decreased by 5.48% to $0.85. The market value of their outstanding shares is at $21.7 million. </li>
<li>8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) stock declined by 5.34% to $2.13. The market value of their outstanding shares is at $267.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMSWA

BNZI

CLPS

EGHT

INSG

KOPN

MINM

SOBR

TROO

UPLD

WETH

12 Information Technology Stocks Moving In Thursday's Intraday Session

Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) has outperformed the market over the past 5 years by 37.68% on an annualized basis producing an average annual return of 50.84%. Currently, Moderna has a market capitalization of $44.44 billion. 
Buying $1000 In MRNA: If an investor had bought $1000 of MRNA stock 5 years ago, it would be worth $8,114.07 today based on a price of $115.95 for MRNA at the time of writing.
<h3>Moderna's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110621_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MRNA

Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today

Clover Health Investments's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NYSE">CLOV</a>) short percent of float has fallen 7.26% since its last report. The company recently reported that it has 35.32 million shares sold short, which is 8.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Clover Health Investments Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110620_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Clover Health Investments has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Clover Health Investments's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Clover Health Investments's peer group average for short interest as a percentage of float is 3.47%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

CLOV

Looking Into Clover Health Investments's Recent Short Interest

ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) has outperformed the market over the past 10 years by 19.25% on an annualized basis producing an average annual return of 30.08%. Currently, ServiceNow has a market capitalization of $161.53 billion. 
Buying $100 In NOW: If an investor had bought $100 of NOW stock 10 years ago, it would be worth $1,406.44 today based on a price of $786.50 for NOW at the time of writing.
<h3>ServiceNow's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110616_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning ServiceNow Stock In The Last 10 Years

Goldman Sachs Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) short percent of float has fallen 5.14% since its last report. The company recently reported that it has 5.33 million shares sold short, which is 1.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.03 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Goldman Sachs Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110615_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Goldman Sachs Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Goldman Sachs Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Goldman Sachs Gr's peer group average for short interest as a percentage of float is 3.10%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Goldman Sachs Gr?

BWX Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) short percent of float has risen 14.29% since its last report. The company recently reported that it has 977 thousand shares sold short, which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.12 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BWX Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110610_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BWX Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing BWX Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BWX Technologies's peer group average for short interest as a percentage of float is 2.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BWXT

Peering Into BWX Technologies's Recent Short Interest

In an episode of The Ramsey Show titled "<a href="https://www.youtube.com/watch?v=9nyM9w6GRhc">Should I Pay Down My Mortgage Or Save For Retirement?"</a>, a caller named Dan from Colorado sought advice on whether to prioritize paying down his mortgage or saving for retirement. At nearly 59 years old, Dan shared his complex financial history, including owning a business for 21 years, facing significant debt, and securing a stable job later in life.
Don't Miss:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
Dan&#8217;s situation is not unique. Many people in their late 50s struggle with debt repayment and retirement savings. Dan&#8217;s annual household income is approximately $145,000, and he has reduced his credit card debt from $92,000 to $5,000. However, he still owes $206,000 on his mortgage and has only $40,000 in retirement savings.
Dave Ramsey, a well-known financial advisor, provided a clear action plan for Dan. "Write a check today and pay off the credit card," Ramsey advised, highlighting the need to cut up the credit card and stop relying on debt.
Next, Ramsey recommended building an emergency fund of three to six months of expenses. Dan mentioned he had started saving and had $7,000 set aside. Ramsey suggested increasing this to around $20,000 to provide a solid financial cushion.
After establishing the emergency fund, Ramsey advised Dan to save 15% of his income for retirement. This equates to about $20,000 annually. "If you will save twenty to thirty thousand dollars a year for 10 years, you&#8217;re gonna have about six or eight hundred thousand dollars," Ramsey explained, illustrating the potential growth of Dan&#8217;s retirement fund.
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
Ramsey highlighted the importance of aggressively paying down the mortgage. By living on a strict budget and allocating significant portions of their income toward the mortgage, Dan and his wife could be debt-free much sooner than anticipated. "Let&#8217;s take fifty [thousand dollars] and throw it at the house a year," Ramsey suggested, projecting that the house could be paid off in about four years.
Finally, <a href="https://www.benzinga.com/personal-finance/24/02/37007973/dave-ramsey-tells-29-year-old-with-1-million-in-debt-hes-going-to-destroy-her-life-as-she-knows-">Ramsey stressed the need for disciplined spending</a> and budgeting to achieve financial stability. "You guys have got to stop spending. You don&#8217;t have time to waste money," he urged, emphasizing that strict budgeting and adherence to the baby steps would lead to long-term financial success.
Several factors come into play when considering whether to pay down a mortgage or save for retirement. Paying off your mortgage can lead to significant interest savings over time and provide the psychological benefit of being debt-free. For example, if you pay an additional $188 per month on a 30-year mortgage, you could pay it off in 20 years, saving around $27,216 in interest.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
However, investing for retirement early can yield higher returns due to the power of compound interest. For instance, starting early allows investments to grow more substantially over time. A consistent investment of $10,000 annually with an average annual return of 8% can grow to nearly $2.8 million over 40 years.
For individuals like Dan, the decision can hinge on their financial situation and goals. If the mortgage interest rate is low and retirement savings are minimal, prioritizing retirement savings might be wiser to take advantage of compound interest and potential employer matches on retirement contributions. Conversely, if the psychological benefit of being debt-free is significant and the mortgage interest rate is relatively high, focusing on paying down the mortgage could be beneficial​.
Ultimately, a balanced approach may work best for many. Paying off high-interest debts first, contributing to retirement savings, and making extra mortgage payments can provide a path to financial stability and growth. <a href="https://www.benzinga.com/money/smartasset">Consulting with a financial advisor</a> can help tailor this approach to individual circumstances, ensuring both immediate financial security and long-term growth.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>

Personal Finance

'You Don't Have Time To Waste Money!' 59-Year-Old With Only $40,000 Saved Asks Dave Ramsey: Pay Down My Mortgage Or Save For Retirement?

Meta Platforms's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/META#NYSE">META</a>) short percent of float has risen 3.91% since its last report. The company recently reported that it has 29.17 million shares sold short, which is 1.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Meta Platforms Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720108823_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Meta Platforms has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Meta Platforms's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Meta Platforms's peer group average for short interest as a percentage of float is 7.02%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Meta Platforms?

Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) has outperformed the market over the past 5 years by 19.94% on an annualized basis producing an average annual return of 33.11%. Currently, Natera has a market capitalization of $13.71 billion. 
Buying $1000 In NTRA: If an investor had bought $1000 of NTRA stock 5 years ago, it would be worth $4,293.85 today based on a price of $111.64 for NTRA at the time of writing.
<h3>Natera's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720108821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTRA

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today

Blue Bird's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NYSE">BLBD</a>) short percent of float has risen 18.94% since its last report. The company recently reported that it has 1.07 million shares sold short, which is 3.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.17 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Blue Bird Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720108818_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Blue Bird has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Blue Bird's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Blue Bird's peer group average for short interest as a percentage of float is 5.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BLBD

Peering Into Blue Bird's Recent Short Interest

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 20 years by 6.68% on an annualized basis producing an average annual return of 14.98%. Currently, W.W. Grainger has a market capitalization of $44.92 billion. 
Buying $1000 In GWW: If an investor had bought $1000 of GWW stock 20 years ago, it would be worth $16,368.85 today based on a price of $915.51 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720108816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In W.W. Grainger 20 Years Ago Would Be Worth Today

Shift4 Payments's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) short percent of float has risen 22.06% since its last report. The company recently reported that it has 9.45 million shares sold short, which is 15.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Shift4 Payments Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720108813_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Shift4 Payments has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Shift4 Payments's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Shift4 Payments's peer group average for short interest as a percentage of float is 4.70%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FOUR

How Is The Market Feeling About Shift4 Payments?

FTAI Aviation's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NYSE">FTAI</a>) short percent of float has fallen 8.96% since its last report. The company recently reported that it has 3.90 million shares sold short, which is 3.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.11 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>FTAI Aviation Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720107920_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for FTAI Aviation has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing FTAI Aviation's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, FTAI Aviation's peer group average for short interest as a percentage of float is 4.39%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FTAI

How Is The Market Feeling About FTAI Aviation?

Progressive's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) short percent of float has fallen 9.18% since its last report. The company recently reported that it has 5.22 million shares sold short, which is 0.89% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Progressive Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720107916_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Progressive has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Progressive's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Progressive's peer group average for short interest as a percentage of float is 2.26%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Progressive's Recent Short Interest

Alibaba Health Info Tech

<h4>Key Takeaways:</h4>

<ul>
	<li>The gross margin on the company&rsquo;s proprietary drug distribution business, its main revenue source, edged down to 6.1% last year</li>
	<li>With the pharma market already well developed, several distribution giants have muscled onto YSB&rsquo;s turf as suppliers to pharmacies and smaller clinics</li>
</ul>

By Molly Wen

Drugs-trading platform&nbsp;YSB Inc.&nbsp;(9885.HK) is feeling the pain from a stock sell-off after delivering its first annual results since listing on the Hong Kong stock market last year.

China&rsquo;s vast online pharmaceutical market counts digital heavyweights such as&nbsp;Alibaba Health&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALBBY#OTC">ALBBY</a>) and&nbsp;JD Health&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/JDHIF#OTC">JDHIF</a>) among its players, but YSB inhabits a niche with relatively tight profit margins as a B2B platform mainly serving smaller pharmacy chains and clinics.

Earnings&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0311/2024031101011.pdf">released</a>&nbsp;early last week highlighted the challenge for YSB.&nbsp; Rising revenues last year and even a profit on an adjusted basis could not prevent a sharp fall in the stock price.

YSB describes itself as the biggest digital provider of comprehensive out-of-hospital drug services in China. Its gross merchandise volume (GMV) rose 18.9% last year to 46.9 billion yuan ($6.5 billion), while operating income rose at the same rate to 16.97 billion yuan. &nbsp;The firm&rsquo;s annual net loss widened to 3.21 billion from 1.5 billion yuan in 2022, as earnings took a one-off hit from the conversion of preferred shares after the IPO.

Using a more representative gauge of business health, the company logged an adjusted profit of 131 million yuan in 2023 against a loss of 125 million yuan the previous year. Gross profit rose 21.3% to 1.74 billion yuan while gross margin edged up to 10.3% from 10.1%.

Investors, however, were unimpressed by those healthier numbers. YSB&rsquo;s shares plunged 9.1% the day after the results and, although they later recovered some ground, suffered a 4.6% fall over four trading days. The stock closed at HK$9.98 last Friday, only half the IPO price of HK$20 last June.

The past six months have been a roller coaster ride for YSB. The company enjoyed a two-month honeymoon with Hong Kong investors after the listing, when the share price reached a high of HK$64.5. However, the price turned south and plummeted 46% in a day after the end of the lock-up period, as the market turned bearish on the company&rsquo;s prospects. YSB&rsquo;s founder and chairman, Zhang Buzhen, announced a 180-day extension to the lock-up but the downward spiral persisted.

YSB&rsquo;s business model in the drugs space is similar to that of e-commerce giant JD.com, connecting drugs factories with pharmacies and clinics via an online trading platform. By the end of 2023, YSB could boast that around 8,100 sellers and more than 650,000 downstream buyers had used its platform.

Like most pharma platforms, as a service provider YSB charges a percentage of transactions as commission. GMV derived from the platform rose 25.8% last year to 28.47 billion yuan, accounting for 60.7% of the total. However, the limited commission rate meant only 870 million yuan in revenue was generated.

YSB gets a bigger revenue boost from its proprietary business, in which it buys drugs from suppliers and distributes them to customers from its own warehouses. Operating income from the self-operated business rose 18.6% last year to 16.04 billion yuan.

The company has built an intelligent supply chain system covering 22 self-owned warehouses in 21 cities. Using the logistics platform, orders can be delivered within a few hours or a day of the order being placed, easing inventory pressure on buyers, the company said. The proprietary business operates on a large scale, but its profit margins are tight: gross margin on this segment dropped 0.1 percentage points to 6.1% last year.

<h3>Competition Intensifies</h3>

YSB&rsquo;s revenues are still growing but the pace of acceleration is slowing. Revenue growth fell from 63.7% in 2021 to 41.4% in 2022, slowing further to 18.9% in 2023. The revenue growth rate for YSB&rsquo;s proprietary services dropped to 18.6% from 41% in 2022, while the rate for the online marketplace business fell to 25.8% from 41.9% in 2022.

Higher commissions charged via the platform and reduced business subsidies may have been factors in the slowdown. The average commission rate rose from 2.9% in 2021 to 3.1% the following year and 3.2% in 2023, calculated as the platform&rsquo;s cut divided by GMV. But the subsidy provided to platform buyers fell from 0.8%, to 0.7% and 0.6% over the same period.

Fiercer competition within the B2B pharma market is squeezing the earnings performance. In the past, big pharma enterprises barely paid any attention to the supply of drugs outside of leading hospitals, which was a relatively small and fragmented market. However, the giants have since joined YSB in its B2B niche, piling on the pressure.

Internet medicine supplier JD Health has launched a pharmaceutical B2B platform, &ldquo;yao.jd.com&rdquo;, while traditional distribution giants&nbsp;Jointown Pharmaceutical&nbsp;(600998.SH) and&nbsp;Shanghai Pharmaceuticals&nbsp;(601607.SH)haveset up their own B2B platforms, &ldquo;youngjoin&rdquo; and &ldquo;yiyaogo.com&rdquo;. &nbsp;In September last year, Jointown Pharmaceutical said it had established 17 &ldquo;companies across the country to provide B2B e-commerce services for small chains, single pharmacies, clinics and other customers.

In the past, market watchers believed Internet platforms could transform the business of drugs distribution and deliver handsome returns. However, over time it has become clear that even the market leader, JD Health, can only turn a profit under non-GAAP standards. The distribution of medicines appears to be stuck in an earnings rut.

Currently YSB commands a price-to-sales (P/S) ratio of about 0.34 times, lower than the 0.78 times for traditional pharmaceutical distributor&nbsp;Sinopharm&nbsp;Group&nbsp;(1099.HK) as net profits remain out of reach. Investors will have to wait and see if YSB can maintain an edge in an increasingly competitive part of the market.

This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Alibaba Health Info Tech

News

Latest news for Alibaba Health Info Tech (OTC:ALBBY) Stock

Thursday, March 21, 2024